Association of anti-PD-(L)1 treatment duration to efficacy in advanced solid tumors: a single center retrospective study
We characterized an anti-PD-(L)1 treated advanced NSCLC and melanoma cohort in which treatment benefit occurs irrespective of treatment duration and long-term benefit is observed off-treatment.
Authors
- Sanna Iivanainen (ORCID: https://orcid.org/0000-0003-1075-1134)
- Jussi Pekka Koivunen (ORCID: https://orcid.org/0000-0001-6425-1640)
- Saara Kuusisalo (ORCID: https://orcid.org/0009-0007-8089-0662)
Institutions
- Oulu University Hospital (FI)
- University of Oulu (FI)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-03-16
- DOI
- https://doi.org/10.1080/07853890.2025.2476729
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09